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ABSTRACT

THE ROLE OF HIF-1α IN INTESTINAL EPITHELIAL BARRIER FUNCTION
IN ALCOHOLIC LIVER DISEASE

Tuo Shao
JULY 7, 2017

Hypoxia inducible factor 1 α (HIF1α) is an oxygen-responsive subunit.
HIF-1α plays a pivotal role in many pathophysiological processes. In addition to
oxygen availability, HIF-1α can be regulated by multiple other factors in response
to various pathophysiological processes. Previous studies showed that hepatic
HIF-1α could be beneficial or harmful in experimental alcoholic liver disease
(ALD). However, the role of intestinal HIF-1α in ALD has not yet been studied.
Given the critical role of the gut-liver axis in ALD, it is important to elucidate the
role of intestinal epithelial HIF-1α in ALD.
In the first chapter, we used wide type (WT) and intestinal epithelial-specific
HIF-1α knockout (IEhif-1α-/-) mice to build chronic ALD model. Alcohol feeding
significantly increased serum levels of ALT and LPS, hepatic triglyceride
concentration, and liver injury in the IEhif-1α-/- mice compare with WT mice.
Alcohol exposure resulted in greater reduction of the expression of intestinal
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epithelial tight junction proteins and antimicrobial substance in IEhif-1α-/- mice.
Bacterial analysis of the fecal samples showed an increased dysbiosis with a
significantly decreased firmicutes/bacteroidetes ratio in IEhif-1α-/- mice compared
to the WT mice exposed to alcohol.
In the second chapter, we used a more severe intestinal damage modeldextran sodium sulfate (DSS) induced colitis with binge ALD model in the same
mice. DSS treatment alone did not affect liver function in both WT and IEhif-1α-/mice. However, serum ALT, AST and LPS levels were significantly elevated in
DSS + alcohol treatment groups, and these elevations were more pronounced in
IEhif-1α-/- mice. DSS induced a marked increase in CRAMP expression in WT
mice. However, this elevation was impaired in the IEhif-1α-/- mice. EtOH exposure
eliminated the increased of CRAMP both in WT and IEhif-1α-/- mice. Therefore,
we used global CAMP-/- mice to identify our hypothesis. As we expected, binge
alcohol on colitis enhance liver injury in CAMP-/- mice compared with WT mice.
In summary, our results demonstrate that intestinal HIF1α is required for
the adaptation response to alcohol exposure-induced changes in intestinal
microbiota and barrier function associated with elevated endotoxemia and
hepatic steatosis and injury.
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OVERVIEW
Alcohol intake remains one of the most important cause of liver cirrhosis in
the Western world. The causal association between alcohol intake and the
development of ALD has been well demonstrated. Alcohol is commonly
consumed worldwide and is associated with a spectrum of liver injury including
simple steatosis or fatty liver, alcoholic hepatitis, fibrosis, and cirrhosis [1,2].
Hepatic steatosis is present in more than 90% of heavy drinkers, is reversible
with abstinence. However, with continued alcohol intake, alcoholic hepatitis (AH)
can be occurred. The prognosis of AH is variable, with nearly 100% survival in
mild cases as compared to high short-term mortality among the most severe
cases. With continued excessive alcohol consumption, patients are at risk for the
development of fibrosis and cirrhosis. Twenty to 40% of patients with steatosis
will develop to fibrosis, of which 8–20% will progress cirrhosis. As in other liver
diseases, patients with cirrhosis are at risk for hepatocellular carcinoma (HCC)
[3,4]. Despite the profound impact of ALD on public health, relatively few
advances have been made in this field. The disease pathogenesis remains
incompletely understood, and medical treatment for ALD has not changed
significantly in 40 years.
Oxygen delivery to the liver and small intestine is significantly decreased
following alcohol ingestion, while the oxygen extraction and consumption are

1

significantly enhanced in both organs [5,6]. Hypoxia plays a role in
pathophysiological conditions such as inflammation, oxidative stress, apoptosis,
and dysregulated barrier function and innate immunity [7–9]. The hypoxia
inducible transcription factors (HIFs) are key elements in the response to hypoxia
in virtually all cells and tissues. HIF consists of an α subunit and a β subunit.
Three α subunits, termed HIF1 α, HIF2 α, and HIF3 α, have been described in
humans, mice, and rats; all bind to a common β subunit named, alternatively,
HIF1β, or the aryl-hydrocarbon-nuclear receptor translocator [ARNT] [10]. HIF-1,
the major transcriptional factor activated during hypoxia, is known to regulate
hypoxia-associated responses [11]. Under normoxic conditions, HIF-1α is rapidly
degraded in a ubiquitin-dependent manner, whereas it escapes degradation
under conditions of hypoxia. Accumulated HIF-1α dimerizes with HIF-1β,
translocates to the nucleus, and regulates numerous gene transcription programs
[8,9,12,13].
HIF stabilization has been reported in acute and chronic alcoholics and in
a murine model of ALD [14–20]. Alcohol-induced fatty liver shares similar clinical
features and underlying pathogenesis with Non-alcoholic fatty liver disease
(NAFLD). Therefore, it is likely that HIF-1α contributes to the development of
hepatic steatosis in ALD as well as in NAFLD. However, the role of HIF-1α in the
pathogenesis of ALD has not clear. To date, there are only six reports describing
the involvement of HIF-1α in alcohol-associated hepatic steatosis, and some
results are contradictory.
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Hypoxia Inducible Factor 1α regulation: A Common Mechanism of Lipid
Accumulation in ALD?
Multiple lines of evidence show that hypoxia and/or HIF may play a role in
hepatic lipid accumulation. Two studies have implied a role for hypoxia in altering
lipid storage in ALD, but their finding are contradictory [14,15]. Both studies used
the HIF-1α

f/f

/AlbCre mice, in which HIF-1α is knockout conditionally in

hepatocytes. The earlier study demonstrated that compared with WT mice,
deficiency of HIF-1α produced less hepatic steatosis [15]. This study
demonstrated that HIF-1α protein expression and its DNA-binding activity was
increased by monocyte chemotactic protein (MCP)-1 which was an upstream
activator. In contrast, the later study demonstrated that alcohol feeding increased
hepatic steatosis and serum triglyceride concentration in hepatic HIF-1α KO mice
[14]. The data showed that lipogenic genes, such as acyl-CoA carboxylase
(ACC)-1, fatty acid synthase (FAS), and stearoyl-CoA desaturase (SCD)-1 were
enhanced in HIF1α KO than in WT mice [14]. These lipogenic genes are
regulated by sterol regulatory element-binding protein (SREBP)-1c, which is
repressed by differentiated embryo chondrocyte 1 (DEC1). DEC1 is one of
transcriptional targets of HIF-1α. The result demonstrated that DEC1 was
increased in alcohol-fed WT but not HIF1α KO mice. Furthermore, prolyl
hydroxylase (PHD) inhibitor dimethyloxaloylglycine (DMOG), were able to
decrease steatosis in HIF-1α KO mice [14].
The discrepant results obtained from the two studies may be due to
differences in the experimental details, for example, intestinal microbiome
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differences of animals, the different dose of ethanol, and the different control
mice. Furthermore, these two studies only focused on determine the role of HIF
in alcohol-induced steatosis, which is an early manifestation of ALD. The role of
HIF signaling in other forms of ALD has not been studied. It is important to
elucidate whether and how HIFs may play a role in the disease progression in
future studies.

Hepatic Hypoxia Inducible Factor 1α and Cytochrome P450 2E1 in ALD
Ethanol is metabolized to acetaldehyde by alcohol dehydrogenase (ADH),
ethanol-inducible cytochrome P450 2E1 (CYP2E1), and catalase (CAT);
acetaldehyde is further oxidized to acetate by mitochondrial aldehyde
dehydrogenase (ALDH2) [21,22]. CYP2E1 potentiates ethanol-induced oxidative
stress and fatty liver, and at high levels, plays a role in ethanol-induced liver
damage as shown by experiments using CYP2E1 inhibitors [23,24]. CYP2E1 has
been examined in ethanol-induced hypoxia in the liver [13]. Studies also showed
that activation of HIF1α could either protect against or promote CYP2E1dependent toxicity.
The study by Wang, XD et al. demonstrated that CYP2E1 knock-in (KI)
potentiates ethanol-induced oxidative stress, fatty liver and liver injury [13]. This
study showed that protein levels of HIF1α and downstream targets of HIF-1α
activation were elevated in the ethanol-fed CYP2E1 KI mice compared to the WT
and CYP2E1 KO mice. Levels of HIF prolyl hydroxylase 2 were reduced in the
ethanol-fed CYP2E1 KI mice, along with the increases in HIF-1α. In situ double
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staining showed that pimonidazole and CYP2E1 were co-localized to the same
area of injury in the hepatic centrilobular tissue. Increased protein levels of HIF1α were also found after acute ethanol treatment of the KI mice. Treatment of
HepG2 E47 cells (which express CYP2E1) with ethanol plus arachidonic acid
(AA) caused loss of cell viability to a greater extent than in HepG2 C34 cells,
which do not express CYP2E1 [13]. These treatments elevated protein levels of
HIF-1α to a greater extent in E47 cells than in C34 cells. The HIF-1α inhibitor (2Methoxyestradiol) also blocked the elevated oxidative stress produced by
ethanol/AA in the E47 cells. These results suggest that blocking HIF-1α
activation and actions may have therapeutic application for protection against
ethanol/CYP2E1-induced hepatic oxidative stress, steatosis, and liver injury [13].
These regulatory mechanisms of CYP2E1 and HIF-1α in chronic ALD were also
demonstrated in acute binge alcohol model [18]. The authors concluded that
binge alcohol promotes acute hypoxic liver injury in mice and humans at least
partly by activating the CYP2E1–HIF1α-dependent apoptosis pathway.
Hepatic Hypoxia Inducible Factor 1α and MicroRNA-1222 in ALD
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate
post transcriptional gene expression via RNA silencing. MicroRNAs have been
reported to control the liver tumor development and aggressiveness [25]. One of
the most abundant miRNAs in the liver is miR-122. Decreases of miR-122 in liver
tissue have been correlated with gain of metastatic properties of liver cancer and
increased mortality [26]. Acute ethanol ingestion leads to a significant rise in miR122 [27]. Recent study shown that miR-122 regulates HIF-1α in hepatocytes in a
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diet-induced

steatohepatitis

animal

model

[28].

More

recently,

it

was

demonstrated that alcoholic steatohepatitis accelerates hepatobiliary tumors by
loss of miR-122 expression with a significant up-regulation of the miR-122 target,
HIF-1α [20]. The study showed that chronic alcohol feeding in adult mice
accelerated diethyl-nitrosamine (DEN) induced liver tumor development with
molecular characteristics of HCC. Increased progenitor cell activation was
triggered in the alcoholic liver tissue microenvironment and was characterized by
high levels of pro-inflammatory signals of both innate (TNFα and MCP-1) and
adaptive immunity, and activation of HIF-1α.

Intestinal Hypoxia Inducible Factor 1α regulation: A Common Mechanism in
Gut-Liver Axis in ALD?
The attenuation of alcohol-induced endotoxemia and liver damage by
antibiotics indicates that endotoxin plays an important role in alcoholic liver
damage [29]. Endotoxins are lipopolysaccharides (LPSs) derived from the cell
walls of gram-negative bacteria. Both dead bacteria and the LPS shed from the
cell walls contribute to the circulating endotoxins. Cellular targets of LPS in the
liver include Kupffer cells, sinusoidal endothelial cells, stellate cells, neutrophils,
and hepatocytes [30]. Normally, Kupffer cells in the liver detoxify endotoxins by
phagocytosis. In Kupffer cells, lipopolysaccharide binding protein (LBP) presents
LPS to CD14, a 55-kDa glycoprotein [31], and activates the MyD88-independent
and dependent signaling pathway through TLR4. TLR4 activation results in the
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production of proinflammatory cytokines such as tumor necrosis factor (TNF)-α
and reactive oxygen species (ROS) that contribute to hepatocellular damage [32].
Alcohol induced intestinal barrier dysfunction increases circulating
endotoxin levels. Endotoxin absorption and leak is impeded by normal mucosal
barrier function, and loss of normal barrier function may play an important role in
causing endotoxemia in alcoholics. The intestines rely on an extensive
underlying vasculature, and therefore are major targets for conditions of
attenuated blood flow and result tissue hypoxia [33]. Both adaptive and
proinflammatory responses have been attributed to conditions of hypoxia [34,35],
and it is now clear that responses to hypoxia include transcriptionally regulated
gene expression coordinated by HIF [36,37]. As important regulators of oxygen
homeostasis, HIF-1α and HIF-2α have been implicated in transcriptional
regulation of anti-inflammatory or tissue-protective-signaling pathways [38,39].
For example, a number of barrier-protective genes are critically regulated by HIFα, including intestinal trefoil factor (ITF), CD73, and multidrug resistance gene-1
(MDR1). Among these, ITF, Muc3, defensins, CRAMP, Claudin-1 and CD73
appear to serve as barrier-protective factors during hypoxia in vivo. There are
also a number of factors other than hypoxia, such as lipopolysaccharide (LPS)
that regulate HIF-1 expression and accumulation. A recent study demonstrates
that long time exposure to LPS impairs HIF-1α induction that, in turn, reduces the
ability of cells to survive and function under hypoxia conditions [40].
A recent study in our lab showed that chronic alcohol feeding decreased
HIF-2α protein levels in the intestines of mice [41]. However, the role of intestinal
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HIF1α has not been studied in ALD. We proposed that HIF-1α plays a critical role
in the intestine by regulating gut microbiota homeostasis and barrier function in
ALD. HIF-1α upregulation in the intestine serves as a compensatory mechanism
to increase factors that reduce gut dysbiosis leading to reduced LPS production
and enhanced barrier function that inhibits the translocation of bacteria and their
products in ALD. We expect that deficiency of intestinal HIF-1α exacerbates gut
dysbiosis,

intestinal

barrier

dysfunction,

increased

LPS

and

bacterial

translocation into the liver, and eventually, liver damage. We also expect that
upregulation of HIF-1α by intestinal pathogenesis, such as inflammatory bowel
disease, provides a feed-back mechanism to limit the intestinal barrier
dysfunction, and deficiency of intestinal HIF-1α leads to further exacerbation of
ALD when the intestine is damaged by inflammatory bowel disease.
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CHAPTER I
INTESTINAL HIF-1α DELETION EXACERBATES ALCOHOLIC
LIVER DISEASE THROUGH INDUCING INTESTINAL DYSBIOSIS AND
BARRIER DYSFUNCTION

INTRODUCTION

Alcoholic liver disease (ALD) ranges from hepatic steatosis to
steatohepatitis, cirrhosis, and, potentially, hepatocellular carcinoma [1]. While
alcohol induces deleterious effects in the liver, it also disrupts the gut microbiota
homeostasis and intestinal epithelial integrity resulting in an increased
permeability, bacterial translocation and release of bacteria-derived endotoxin
into the circulation [2-4]. Clinical and experimental studies have demonstrated
that serum levels of lipopolysaccharide (LPS) are, indeed, increased in alcoholic
subjects [5, 6]. LPS binding to Toll-like receptors (TLRs) on the surface of Kupffer
cells leads to an elevated pro-inflammatory cytokine production, which, in turn,
damages hepatocyte function [7, 8].
Intestinal barrier function is key to preventing the increased bacterial
translocation by alcohol [6, 9, 10]. Goblet cells in the intestinal epithelium
produce protective trefoil factors and mucins, which are abundantly core
glycosylated and either localized to the cell membrane or secreted into the lumen
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to form the mucus layer [11, 12]. The mucus is the first barrier that intestinal
bacteria meet, and pathogens must penetrate it to reach the epithelial cells [13,
14]. Additionally, trefoil factors stimulate expression and secretion of mucins and
play a role in building/modifying the mucus layer and promoting epithelial tight
junction integrity [15]. Intestinal Paneth cells produce antimicrobial peptides that
are retained in the mucus layer, thereby concentrating their bactericidal activity
close to the epithelium. Together, Paneth and Goblet cells prevent bacterial
invasion to some extent, and thereby play a prominent role in the innate immune
surveillance of the gut [12]. A single layer of epithelial cells forms the main
physical barrier between the lumen and mucosal tissues. The paracellular space
is sealed by tight junctions (TJ), which regulate the flow of small molecules
through the composition of claudins and other proteins in the junctional complex
[16]. IgA production and other intestinal immune-regulators provide protection
against bacterial transcytosis [17]. Recent studies demonstrate that targeting
intestinal barrier function may be an effective strategy in the prevention/treatment
of ALD [18].
The intestines are supported by an extensive underlying vasculature, and
are therefore susceptible to conditions related diminished blood flow and
concomitant tissue hypoxia [19, 20]. It is now clear that the responses to hypoxia
include transcriptionally regulated gene expression coordinated by the
transcription factor hypoxia-inducible factor (HIF) [21]. HIF-1α and HIF-2α have
been implicated in transcriptional regulation of anti-inflammatory or tissueprotective-signaling pathways [22-24]. A number of barrier-protective genes are
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critically regulated by HIF-1α, including intestinal trefoil factor (ITF), CD73, Pglycoprotein (P-gp), cathelicidin, claudin-1, muc3 and β-defensin-1(DEFB1) [19,
25-30]. While hypoxia is an important factor for HIF-1α protein stabilization, there
are also a number of factors other than hypoxia, such as LPS, that regulate HIF1α expression and accumulation [31]. A recent study demonstrates that long time
exposure to LPS impairs HIF-1α induction, which then reduces cell viability and
function under hypoxia conditions [32].
Disruption of epithelial HIF-1α resulted in an increased epithelial
permeability, as shown in murine colitis models [33-36]. Our previous study
showed that long-term exposure to alcohol decreased epithelial HIF-2α protein
expression in mice [37]. We also demonstrated that knockdown of HIF1/2α
resulted in an increased permeability and a decreased trans-epithelial electrical
resistance (TEER) in Caco-2 cells [37, 38]. However, it is unknown whether
intestinal epithelial HIF-1α is critical in maintaining intestinal barrier function in
response to alcohol exposure in mice.
In the present study, we discovered that intestinal epithelial specific HIF-1α
knockout (IEhif1α-/-) worsens alcohol-induced liver injury. We showed that alcohol
exposure in IEhif1α-/- mice resulted in a more severe dysbiosis, bacterial
translocation and liver injury. IEhif1α-/- mice had decreased levels of antimicrobial
peptide in the intestine and an increased intestinal inflammation. Probiotic
administration decreased alcohol-induced liver injury in wild type (WT) mice but
not in IEhif1α-/- mice. Sterilizing the gut using non-absorbable antibiotics
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attenuated liver-injury in IEhif1α-/- mice. Our results suggest that targeting
intestinal HIF-1α may be a strategy for preventing ALD.

MATERIALS AND METHODS
Animal Models of Alcohol Feeding and Drug Administration
C57BL/6J, hif1α-fl/fl, and Villin-Cre mice were purchased from Jackson
Laboratory (Bar Harbor, ME). IEhif1α-/- mice were generated by crossing hif1α-fl/fl
and Villin-Cre mice as previous described [39]. The Cre mice were used as
controls in this study (WT). Eight to ten-week old male mice (WT and IEhif1α-/-)
were pair-fed a Lieber-DeCarli liquid diet containing alcohol (AF) or isocaloric
maltose dextrin (PF). In the first week, all groups of mice were given modified
Lieber-DeCarli liquid diet without alcohol to acclimate the mice to the liquid diet.
Starting at week 2, alcohol was gradually introduced and increased to 5% (w/v)
at the end of the week and was continued at 5% for 24 days. This modified
Lieber-DeCarli diet contained 17% of energy as protein, 40% as fat, 7% as
carbohydrate, and 35% as either alcohol (5% w/v) or isocaloric maltose dextrin
(Research Diets, New Brunswick, NJ). A group of mice was treated with nonabsorbable antibiotics (Polymyxin B, 150 mg/kg BW/day and Neomycin, 200
mg/kg BW/day) at day 12 of the 5% alcohol-feeding period. Control mice were
gavaged daily with an equal volume of vehicle (water). Lactobacillus rhamnosus
GG was supplemented to one group of mice at a dose of 109 CFU/day. A group
of mice was administered 8 mg of dimethyloxalylglycine (DMOG, Cayman
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Chemical, Ann Arbor, MI) intraperitoneally every other day for the last 2 weeks of
ethanol diet feeding. Intestinal tissues of mice treated with alcohol using same
protocol described above for 48 days (from another study) were used for HIF-1α
analysis. All animal protocols were approved by the Institutional Animal Care
and Use Committee of the University of Louisville.

Histological analysis
The

liver

and

small

intestine

tissues

were

collected

in

4%

paraformaldehyde and then imbedded in paraffin. Tissues were cut into 5μm
sections and stained with hematoxylin and eosin (H&E) and analyzed by light
microscopy. For hepatic lipid accumulation analysis, frozen liver sections were
stained with Oil Red O to visualize neutral lipids. Nuclei were counterstained with
hematoxylin.

Neutrophil

accumulation

in

the

livers

was

assessed

by

chloroacetate esterase (CAE) (Sigma, St. Louis, MO) staining. Intestine and liver
macrophages were evaluated by F4/80 immunofluorescent staining.

Tissue triglyceride
Liver tissues were homogenized in distilled water and the homogenate was
collected for lipid extraction. Triglyceride content was determined using
commercially available colorimetric kits (Thermo Scientific, Waltham, MA).

Serum ALT assay
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Mouse serum was collected by orbital vein bleeding at time of euthanasia.
Serum alanine aminotransferase (ALT) levels were analyzed by Piccolo Xpress
system (ABAXIS, Union City, CA).

Endotoxin assay
All material used for harvesting blood and measuring endotoxin was
pyrogen free. An endpoint chromogenic Limulus amebocyte lysate (LAL)
endotoxin kit was used to determine plasma LPS levels according to the
manufacturer’s protocol (Lonza, Basel, Switzerland).

Immunofluorescent staining of FFPE tissue.
Formalin-fixed paraffin embedded (FFPE) tissue was processed for
staining as described previously with certain modifications [34]. Following
deparaffinization, antigen retrieval was performed in unmasking solution (Vector
Laboratories, Burlingame, CA) for 20 min at 125 oC in a Decloaking chamber
(Biocare Medical, Pacheco, CA). Unreacted aldehydes were quenched for 10
min with 1% NaBH4. Prior to blocking, ImageIT enhancer (Invitrogen, Carlsbad,
CA) was applied to each section. Non-specific antibody binding was blocked with
either 1% IgG-free BSA or 5% Normal donkey serum (Jackson Immuno, West
Grove, PA) in TBS (Tris-buffered saline), depending on the antibodies used.
Primary antibodies were incubated overnight at 4oC. Sections were washed with
TBS, and AlexaFluor-conjugated secondary antibodies (Invitrogen) were applied
for 30 min at room temperature. DAPI counterstain (Invitrogen) was used to
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image nuclei and slides were mounted with ProLong gold (Invitrogen). Primary
antibodies used were: E. coli (Abcam, Cambridge, MA), F4/80 (Abcam), Claudin1 (Santa Cruz, Dallas, TX), and Occludin (Santa Cruz).

Quantitative PCR (qPCR)
Total RNA from liver and ileal tissues was isolated with TRIzol according to
manufacturer's protocol (Invitrogen), and total RNA was reverse transcribed (RT)
using Sensiscript Reverse Transcriptase and oligo(dT) (Applied Biosystems,
Foster City, CA) to yield the cDNA. The cDNA was amplified in 96-well reaction
plates with a SYBR green PCR Master Mix (Applied Biosystems) on an ABI 7500
real-time PCR thermo cycler. The primers used in this study are listed in the
Supplementary Table 1. Data were expressed as relative mRNA levels using the
△△CT method.
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Table 1. Primers used for qPCR

Gene

Forward sequence 5' -> 3'

Reverse sequence 5' -> 3'

CCA CCT CGT GAA CGA AGA TT

ACC ACC ACG ACC TCG AAT AG

ATCTACCTGGGAGGCGTCTT

GAGTGGCACAAGGAACTGGT

IL-6

TGGAAATGAGAAAAGAGTTGTGC

CCAGTTTGGTAGCATCCATCA

IL-1β

TTCATCTTTGAAGAAGAGCCCAT

TCGGAGCCTGTAGTGCAGTT

ACCACAGTCCATGCCATCAC

TTGAGGTGGTTGTGGAAAAG

AAACTCAAAKGAATTGACGG

TCACRRCACGAGCTGAC

CAG CAC GTG AAG GTG GGG AC

CCT TGC GGT TGG CTT CAG AT

CCT TGC GGT TGG CTT CAG AT

CACCGCTACACATGGAG

ATACTTCAAAAGCAATTTTCCTTTAT

TTGTCTGAGATGGCCTCAGGTGGTAAC

CATGAGGGTCTTGTATCTCCTCT

CCTCCTCATGGCTTTTTGCAGC

TCTCTACCGTCTCCTGGACCTG

CCACATACAGTCTCCTTCACTCG

LL-37

AGGATTGTGACTTCAAGAAGGACG

GTTTATTTCTCAGAGCCCAGAAGC

hBD-1

ATACTTCAAAAGCAATTTTCCTTTAT

TTGTCTGAGATGGCCTCAGGTGGTAAC

hBD-2

CATGAGGGTCTTGTATCTCCTCT

CCTCCTCATGGCTTTTTGCAGC

CCCATCATTGCAATAGCACC

GTTCAACTTCTGCTCCTGA

AAC TGT CCC CGG GAC CTC

GCG CTC TGC ACT GTG CTT T

ATCTCGGCGAAGCAAAGAGTC

TGGGGAAGTGGCAACTGAT

GTAACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

name
SERBP-1
TNF-α

MCP-1
Universal
bacteria
Akkermans
ia
Lactobacill
us
βDefensin-1
βDefensin-2
CRAMP

P-gP
CYP2E1
HIF-1α
18S
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Western blot analysis
Liver and ileal tissues were lysed on ice for 30 min in IPB (50 mM Tris·HCl,
pH 7.4, 150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100,
1 mM PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 x g for 10
min. The supernatants were collected. An appropriate amount of protein in total
tissue lysates was resolved by SDS-polyacrylamide gel electrophoresis and
transferred onto a polyvinylidene difluoride membrane (Whatman, Sanford, ME).
Membranes were blocked for 1 h in Tris-buffered saline/Tween 20 (10 mM Tris–
HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk
and incubated overnight at 4°C with the different primary antibodies diluted in
blocking buffer. Subsequently, membranes were incubated with peroxidaseconjugated second antibodies. Following treatment with supersignal west HRP
substrate (MilliporeSigma, Billerica, MA), protein bands were detected by a
ChemiDoc Molecular Imager (Bio-Rad, Hercules, CA). Data were normalized to
b-actin.

Bacterial cultures
Mouse fecal pellets were collected and processed as described previously
[45]. Briefly, fecal pellets were suspended in PBS at a concentration of 1g
feces/15 ml PBS and vortexed vigorously for 5 minutes. Serial dilutions of fecal
homogenates were prepared in sterile Lysogeny Broth (LB) medium (BD
Biosciences, San Jose, CA) in 15-ml tubes. The tubes were shaken for 24-48 h
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at 37oC under aerobic conditions. Bacterial growth was monitored by measuring
OD600.

Statistical analysis
Statistical analyses were performed using the statistical computer
package, GraphPad Prism version 6, (GraphPad Software Inc., San Diego, CA,
USA). Results are expressed as means ± SEM. Statistical comparisons were
made using one-way analysis of variance (ANOVA) with Tukey’s post hoc test, or
Student’s t-test where appropriate. Differences were considered to be significant
at P<0.05.

RESULTS

IEhif1α-/- Mice Have Exacerbated Alcohol-Induced Hepatic Steatosis
To examine the role of the intestinal HIF-1α in experimental alcoholic liver
disease, we generated intestinal epithelial specific knockout mice (IEhif1α-/-) by
crossing hif-1αfl/fl mice with Villin-Cre mice. To confirm the deletion effectiveness,
the

chemical

intraperitoneal

hypoxia
injection,

inducer,
and

CoCl2,

liver

and

was

administered

intestine

HIF-1α

to

mice

protein

via
was

immunoblotted. CoCl2 induced a prominent increase in HIF-1α protein in the liver,
but the changes were minimal in the intestine, indicating the effectiveness of the
epithelial specific HIF-1α deletion (Fig.1). Chronic alcohol feeding for 24 days
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increased hepatic micro- and macro-steatosis in both WT and IEhif1α-/- mice.
This effect was more pronounced in IEhif1α-/- mice, as shown in Fig. 2A and 2B.
Liver to body weight ratio was not changed in WT mice, but was significantly
increased in IEhif1α-/- mice (Fig. 2C). Confirming the histological findings, liver
triglyceride level was increased by alcohol feeding in WT mice (not statistically
significant), but it was markedly increased in the IEhif1α-/- mice (Fig. 2D). Alcohol
feeding significantly increased hepatic SREBP-1 mRNA level in both WT and
IEhif1α-/- mice, but the effect was much greater in IEhif1α-/- mice compared to WT
mice, indicating an increased lipogenesis in IEhif1α-/- mice exposed to alcohol
(Fig. 2E). Fasting serum glucose level was slightly decreased by alcohol feeding.
However, the KO mice had significantly higher glucose levels compared to WT
mice fed alcohol (Fig. 3A). Serum triglyceride (Fig. 3B) and total cholesterol
levels (Fig. 3C) in IEhif1α-/- mice were slightly lower under pair-fed conditions
compared to WT mice. WT mice had decreased total cholesterol and triglyceride
levels, which were significantly increased in IEhif1α-/- mice after alcohol feeding.
Alcohol feeding did not affect serum levels of LDL (Fig. 3D) in either WT or
IEhif1α-/- mice, but serum HDL (Fig. 3E) and VLDL levels (Fig. 3F) were
significantly increased in IEhif1α-/- mice in response to alcohol feeding.
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Figure1. Expression of HIF-1α in different organs with or without the hypoxia
inducer. CoCl2 (intraperitoneally injected with 60 mg/kg, mice were sacrificed at
3h after CoCl2 injection) is used as a chemical hypoxia treatment, HIF-1α protein
levels in liver (A) and intestinal (B) tissues. (*P<0.05).
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IEhif1a -/-
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AF

Figure 2. Intestinal Hif1α KO (IEhif1α-/-) mice display exacerbated chronic
alcoholic liver injury and steatosis. WT and IEhif1α-/- mice were fed pair-fed liquid
diet (Lieber DeCarli) containing either 5% alcohol (alcohol-fed, AF) or isocaloric
maltose–dextrin (pair-fed, PF) for 24 days. (A) Hematoxylin and eosin staining of
the liver sections of PF and AF WT and IEhif1α-/- mice. Original magnification,
×10. (B) Oil red O staining of the liver neutral lipids of PF and AF WT and
IEhif1α-/- mice. (C) Liver weight to body weight ratio of WT and IEhif1α-/- mice fed
PF or AF diets. (D) Quantification of hepatic triglyceride content. (E) Gene
expression of SREBP-1 in liver tissues. *P<0.05, **P<0.01, ***P<0.001.
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Figure 3. Effect of alcohol on lipid metabolism. Mice were fed alcohol-containing
Lieber DeCarli diet for 24 days as described in the Material and Methods. The
serum level of glucose (A), triglyceride (B), total cholesterol (C), low-density
lipoprotein cholesterol (D), high-density lipoprotein cholesterol (E), and very lowdensity lipoprotein cholesterol (F) were detected in WT (PF, AF) and the KO (PF,
AF) groups. (*P<0.05, **P<0.01, ***P<0.001).
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Alcohol Increases Hepatic Inflammatory Response in IEhif1α-/- mice
Next, we analyzed alcohol exposure-induced inflammation in IEhif1α-/- mice.
Alcohol feeding increased hepatic inflammation in IEhif1α-/- mice as evidenced by
increased inflammatory foci (Fig. 2A arrows). As shown in Fig. 4A, IEhif1α-/- mice
had an increased infiltration of cytotoxic neutrophils (CAE staining) in the liver
compared

to

WT

immunohistochemical

mice

in

staining

response
using

to

F4/80

alcohol
revealed

feeding.
more

Additionally,
inflammatory

macrophages in the livers of IEhif1α-/- mice (Fig. 4B). More intense neutrophil
infiltration and macrophage activation in livers of IEhif1α-/- mice were associated
with elevated gene expression of the pro-inflammatory cytokines, tumor necrosis
factor alpha (TNF-α) and IL-6, and the chemokine MCP-1 (Fig. 4C, 4D and 4E).
Hepatic TLR4 protein level increased in IEhif1α-/- mice after alcohol exposure (Fig.
5). Serum levels of ALT were increased in both WT and IEhif1α-/- mice (Fig. 4F).
Taken together, these results demonstrate that IEhif1α-/- mice have enhanced
hepatic steatosis and inflammation upon chronic alcohol exposure.
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Figure 4. Inflammatory responses in EtOH-induced liver injury. (A) Chloroacetate
esterase (CAE) localization (cell-localized fuchsia staining) in livers of WT and
IEhif1α-/- mice fed PF and AF diets for 24 days. Original magnification, ×10.
Arrows indicates neutrophil infiltration. (B) F4/80 staining of the liver tissues of PF
and AF WT and IEhif1α-/- mice. Arrows indicate positive staining. DAPI (blue)
was used to counterstain nuclei. Original magnification, ×10. (C, D, E) Hepatic
gene expression of proinflammatory cytokines TNF-α, IL-6 and the chemokine
MCP-1, respectively. (F) Serum alanine aminotransferase (ALT) activities of PF
and AF WT and IEhif1α-/- mice. *P<0.05, **P<0.01, ***P<0.001.
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Figure 5. Effect of alcohol on hepatic Toll-like receptor 4 protein expression.
Mice were fed alcohol-containing Lieber DeCarli diet for 24 days as described in
the Material and Methods.
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Alcohol Increases Hepatic Fibrosis in IEhif1α-/- mice
Sirius Red staining of the liver sections showed a marginal increase of
fibrosis in WT mice by alcohol feeding. IEhif1α-/- mice had a significant increase
in Sirius Red positive area compared to WT mice (Fig. 6A). The gene expression
of fibrogenic factors, collagen α1 and αSMA, were marginally increased in the
WT mice, but significantly increased in IEhif1α-/- mice, by alcohol feeding (Fig. 6B
and 6C). This suggests that intestinal epithelial HIF-1α depletion exacerbates
hepatic fibrosis by alcohol exposure.
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Figure 6: IEhif1α-/- mice have exacerbated liver fibrosis following alcohol
treatment. (A) Sirius Red staining of the liver sections. The degree of fibrosis was
evaluated by semi-quantification of Sirius Red positive area. (B) gene expression
of Collagen α1 and αSMA in the liver tissues. *P<0.05, **P<0.01, ***P<0.001.
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IEhif1α-/- Mice Exhibit Gut Dysbiosis and Hepatic Bacterial Translocation
Previous studies showed that ALD is associated with gut dysbiosis and
endotoxin release. We next determined whether gut bacterial homeostasis and
the translocation of bacteria and bacterial products from the intestine into the
circulation are affected by the absence of intestinal Hif1α. Fecal samples were
analyzed by 16S ribosomal RNA bacterial primer sets to evaluate the effect of
alcohol on bacterial overgrowth. As shown in Fig.7A, total bacterial load was
unchanged in the WT mice, but significantly increased in the IEhif1α-/- mice after
24 days of chronic alcohol feeding, indicating a bacterial overgrowth.
Metagenomic analysis showed that alcohol feeding markedly increased phylum
levels of Bacteroidetes and decreased Firmicutes in IEhif1α-/- mice (Fig. 7B).
Further, 16S PCR analysis showed that Akkermansia spp. was increased in
IEhif1α-/- mice but not in the WT mice (Fig. 7C). Interestingly, Lactobacillus spp.
was decreased by alcohol in WT mice, and was almost undetectable in IEhif1α-/mice (Fig. 7D). These data indicated that IEhif1α-/- mice had an exacerbated gut
dysbiosis following 24-day alcohol exposure. Intestinal antimicrobial peptides,
secreted by epithelial cells such as enterocytes, Goblet and Paneth cells, play a
critical role in gut microbiota homeostasis.

Interestingly, alcohol exposure

decreased the numbers of Goblet cells in the mucosal tissues of both WT and
IEhif1α-/- mice, but the effect was exacerbated in IEhif1α-/- mice (Fig. 7E). βdefensins are the dominant classes of antimicrobial peptide secreted by the
epithelium. The gene expression of β-Defensin-1 and -2 was increased by
alcohol exposure in the ileal tissue of WT mice, while it remained unchanged in
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the IEhif1α-/- mice, following alcohol exposure (Fig. 7F and 7G). Cathelicidin
related antimicrobial peptide (CRAMP) is the only member of cathelicidin antimicrobial peptide family in mice. Alcohol exposure significantly reduced CRAMP
expression in both WT and IEhif1α-/- mice (Fig. 7H).
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Figure 7. Effect of Hif1α on alcohol-induced dysbiosis. (A) The total bacterial
load in the cecum of PF and AF WT and IEhif1α-/- mice. (B) Phylum levels of
microbiota in fecal samples of PF and AF WT and IEhif1α-/- mice. (C, D)
Akkermansia (Verrucomicrobia phylum) and Lactobacillus (Firmicutes phylum)
levels of PF and AF WT and IEhif1α-/- mice.

(E) Goblet cell staining and

quantification of the ileal tissues of PF and AF WT and IEhif1α-/- mice. (F, G, H)
β-Defensins (β-Defensins-1, 2) and cathelicidin-related antimicrobial peptide
(CRAMP) gene expression in the ileal tissues of PF and AF WT and IEhif1α-/mice. *P<0.05, **P<0.01, ***P<0.001
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Induction of HIF in the Intestinal Epithelial Cells Inhibits Mouse Fecal
Bacterial Growth
The role of intestinal HIF-1α in gut lumen bacterial growth was further
analyzed in an in vitro assay. T84 intestinal epithelial cells were incubated with
DMOG (Dimethyloxaloylglycine), a HIF-1α activator. The conditioned medium
was added to the mouse fecal bacterial culture in LB media, and bacterial growth
rate was determined. As shown in Fig. 8A, DMOG itself did not change the fecal
bacterial growth over the period of 6 hours. However, DMOG-conditioned
medium significantly inhibited bacterial growth at the 5- and 6-hour time points,
indicating HIF-1α-mediated secreted factors from epithelial cells likely possess
anti-microbial capacity. To further confirm whether HIF-1α activation can increase
anti-microbial capabilities, we determined anti-microbial peptide expression in
T84 cells after treatment with DMOG. The gene expression of human βDefensin-1, -2 (hBD-1, 2) and human cathelicidin related antimicrobial peptide
(LL-37) was increased significantly by DMOG in T84 cells (Fig. 8B-D), indicating
HIF-1α activation increases antimicrobial peptide expression in epithelia cells.
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HIF1α-deficiency Induces Intestinal Barrier Dysfunction After Chronic
Alcohol Exposure
Increased bacterial translocation indicates intestinal barrier dysfunction.
Immunofluorescent staining showed a decreased expression of the TJ proteins,
occludin and claudin-1, in the ileal tissues of WT mice after alcohol exposure.
Importantly, these decreases were more severe in IEhif1α-/- mice (Fig. 9A and
9B). The decreased TJ protein expression was associated with the disruption of
intestinal protective factors, such as ITF and P-gp. ITF plays an important role in
intestinal mucus layer protection. Protein level of ITF was significantly lower in
the IEhif1α-/- mice compared to the WT mice (Fig. 9C). Furthermore, P-gp (also
known as multidrug resistance protein 1, MDR1) plays an important role in
overall intestinal barrier integrity, and it was upregulated by alcohol in WT mice.
This adaptive increase was, however, eliminated in the IEhif1α-/- mice (Fig. 9D).
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Immunoflorescent staining of occludin (green) and claudin-1 (blue) in the ileal
tissues of PF and AF WT and IEhif1α-/- mice. DAPI (blue) was used to
counterstain nuclei. Original magnification, ×10. (C) ITF protein Western blotting
and quantification of ileal tissues of PF and AF WT and IEhif1α-/- mice
normalized by β-actin. (D) P-gp gene expression in ileal tissues of PF and AF WT
and IEhif1α-/- mice. *P<0.05, **P<0.01, ***P<0.001.
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Alcohol Increases Intestinal Inflammatory Response in IEhif1α-/- Mice
Histologic examination revealed a prominent inflammatory response in the
ileum of IEhif1α-/- mice exposed to alcohol (Fig. 10A). Alcohol feeding significantly
increased macrophage-like appearance in Peyer's patches (PPs), a major
component of the gut-associated lymphoid tissue which serve as important
antigen entry sites in mucosal immunity. The PP domes were irregular, and the
surrounding villi were sparse and atrophic (Fig. 10A), indicating an increased
intestinal inflammatory response in the small intestines of IEhif1α-/- mice exposed
to alcohol. We further analyzed alcohol-induced intestinal inflammation in the
IEhif1α-/- mice. Immunofluorescent analysis revealed an increased number of
cells expressing F4/80 in alcohol-treated-IEhif1α-/- mice compared with WT mice
(Fig. 10B). Intestinal inflammation in the IEhif1α-/- mice by alcohol exposure was
further confirmed by the increased mRNA levels of pro-inflammatory cytokines,
IL-6, IL-1β and TNF-α (Fig. 10C-E).
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Figure 10. Effect of Hif-1α on intestinal inflammation. (A) HE staining of ileal
tissues. Original magnification, ×10. PF-fed WT and IEhif1α-/- mice show normal
architecture and rounder, light "hollows" (black arrows) in the epithelium
representing the apical cytoplasm of the goblet cells, which is filled with mucincontaining secretory vesicles. Abundant infiltrating cells showed a macrophagelike appearance in Peyer's patches (PPs) (white arrows), Peyer's patches’ domes
were irregular, and the surrounding villi were sparse and atrophic in ethanoltreated IEhif1α-/- mice. (B) Immunofluorescent staining of F4/80 (red) showed
increased macrophages in ileum of AF IEhif1α-/- mice (arrows). DAPI (blue) was
used to visualize nuclei. Original magnification: ×10. (C, D, E) Ileum IL-6, IL-1β
and TNF-α mRNA levels. *P<0.05.
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Alcohol Increases Intestinal Permeability and Bacterial Translocation
Increased intestinal barrier damage and inflammation leads to higher
intestinal permeability and induces greater bacteria translocation. To further
determine the role of epithelial HIF-1α in alcohol-induced translocation of
bacteria/bacterial products to the liver, we analyzed circulating LPS concentration
and Escherichia coli (E. coli) protein in the liver. As shown in Fig.11A, serum LPS
level was slightly elevated by alcohol feeding in the WT mice, but significantly
increased in IEhif1α-/- mice. Furthermore, hepatic contents of E. coli protein were
increased in WT mice following alcohol exposure, and this increase was more
pronounced in IEhif1α-/- mice, as evaluated by immunofluorescent staining of
hepatic tissues (Fig. 11B).
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Figure 11. Effect of Hif-1α on gut permeability and bacterial translocation. (A)
Serum LPS levels. (B) Hepatic staining of E. coli protein (green staining, arrows,).
DAPI (blue) was used to visualize nuclei. Original magnification, ×10. *P<0.05
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Antibiotic Sterilization of the Gut Reduces Alcohol-Induced Liver Fat
Accumulation and Injury
To further elucidate the role of gut bacteria in alcohol-induced liver
steatosis and injury in IEhif1α-/- mice, non-absorbable antibiotics (ABx; Polymyxin
B and Neomycin) were administered to the mice exposed to alcohol for 12 days.
ABx treatment decreased hepatic fat accumulation (Fig. 12A), liver triglyceride
levels (Fig. 12B) and serum ALT levels (Fig. 12C) in both WT and IEhif1α-/- mice.
However, these effects were more pronounced in IEhif1α-/- mice. These results
support the concept that gut dysbiosis is critical in alcohol-induced hepatic
steatosis and injury in the IEhif1α-/- mice.
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Figure 12. Effects of non-absorbable broad-spectrum antibiotics (ABx) on EtOHinduced liver steatosis and injury. WT and IEhif1α-/- mice were fed 5% alcohol
liquid diets for 24 days. Antibiotics treatment was started at day 12 after alcohol
feeding, and mice were gavaged daily until harvesting. (A) Oil red O staining of
hepatic tissues. Original magnification, ×10. (B) Quantification of hepatic
triglyceride content. (C) Serum alanine aminotransferase (ALT) activities.
**P<0.01.
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HIF-1α is Required for the Protective Effect of Lactobacillus rhamnosus GG
in ALD
Our previous studies have shown that the probiotic, LGG, protects against
ALD by increasing intestinal HIF signaling and modifying gut bacterial
homeostasis [38]. In this study, we tested whether HIF-1α is required for the
protective effects of LGG. IEhif1α-/- and WT mice were fed 5% (w/v) alcohol for
10 days and a single dose of alcohol was gavaged in the morning of last day, as
described previously [37]. LGG was administered by gavage at a dose of 109
CFU/day along with alcohol exposure. Agreeing with previous study, LGG
administration significantly reduced hepatic fat accumulation resulting from
alcohol exposure in WT mice. However, these protective effects were diminished
in IEhif1α-/- mice, suggesting that HIF-1α is required for the beneficial effects of
LGG in ALD treatment (Fig. 13A, B).
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Figure 13. Effects of Hif-1α on Lactobacillus rhamnosus GG treatment in ALD. (A)
HE staining revealed LGG administration reduced steatosis by alcohol exposure
in WT mice. However, LGG protective effects were diminished in IEhif1α-/- mice.
(B) Quantification of hepatic triglyceride content. *P<0.05, **P<0.01.
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DISCUSSION
The gut-liver axis plays an important role in the pathogenesis of chronic
liver disease in experimental animals and humans. Intestinal dysbiosis and the
disruption of the intestinal barrier integrity by alcohol are prominent features of
ALD. Previous studies demonstrated that alcohol exposure-associated changes
in gut metabolites and antimicrobial peptide production contribute to ALD [6, 9,
18]. The mechanisms by which alcohol disrupts the antimicrobial peptide
response leading to dysbiosis and intestinal barrier dysfunction are not fully
understood. In this study, we investigated the role of intestinal HIF-1α in the gutliver axis in ALD using intestinal epithelial specific HIF-1α deficient mice. In
IEhif1α-/- mice, 24-day alcohol exposure diminished the HIF-1α-mediated
adaptive response on intestinal integrity and gut bacterial homeostasis, resulting
in an exacerbated liver steatosis, inflammation, fibrosis and injury.
Pathogenic bacteria overgrowth and a reduction of beneficial bacteria
constitute gut dysbiosis in ALD. The gut microbiota homeostasis is controlled by
bacteria-bacteria and bacteria-host interactions under both healthy and diseased
conditions. Alcohol exposure disrupts microbiota homeostasis. However, the gut
mucosal response has adaptive mechanisms to restore homeostasis by
increasing antimicrobial substances. We postulate that epithelial HIF-1α
represents such an adaptive mechanism. We speculated that disruption of HIF1α signaling in the intestine would cause/exacerbate gut dysbiosis following
alcohol exposure. Consistent with our previous research, 24-day alcohol
exposure changed gut microbiota homeostasis slightly in WT mice. However,

48

depletion of intestinal epithelial HIF-1α resulted in a more severe dysbiosis. The
IEhif1α-/- mice had reduced Firmicutes and increased Bacteroidetes in their fecal
samples. Such a change has been shown in a mouse model of ALD using
intragastric feeding [40]. At the bacterial species level, Akkermansia (Akk), gramnegative anaerobic bacteria, were not affected by alcohol in WT mice, but were
increased in the IEhif1α-/- mice. The role of Akk in the ALD remains elusive.
Supplementation with Akk showed a protective effect in ALD [41], while an
endogenous increase of Akk may impact the intestinal innate immune system
and facilitate bacterial translocation by degrading the intestinal mucus [42, 43].
The causal relation between an intestinal increase in Akk and intestinal integrity
needs further study. Interestingly, Lactobacillus bacteria were markedly depleted
by 24-day alcohol exposure in WT mice, and this decrease was even more
pronounced in IEhif1α-/- mice. A recent study demonstrated that Lactobacillus
utilized saturated long-chain fatty acids, and these saturated fatty acids were
beneficial in ALD treatment [44]. A short-chain fatty acid, butyrate, plays an
essential role in epithelial cell nutrition and intestinal physiology. Butyrate
regulates epigenetic processes through HDAC inhibition. Intestinal consumption
of butyrate causes local hypoxia leading to increased HIF-1α expression.
Although Lactobacillus itself does not produce butyrate, studies have shown that
Lactobacillus promotes eubiosis, thereby resulting increased butyrate production.
Butyrate-producing bacteria are mainly in the phylum Firmucutes, which was
decreased by alcohol in our study. Furthermore, the decrease of Lactobacillus in
ALD is consistent with the beneficial effect of LGG supplementation on ALD as
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shown by several authors [37, 38, 45-47]. Taken together, our results
demonstrate that depleting intestinal epithelial HIF-1α causes gut dysbiosis
following a 24-day alcohol feeding regimen in mice.
HIF-1α is a master transcription factor regulating a variety of genes in the
intestine. Anti-microbial peptides, β-defensin and CRAMP, are regulated by HIF1α [27, 30]. Paneth cell-derived β-defensins and epithelial cell- and microphagederived CRAMP regulate gut microbiota homeostasis. Our results showed that βdefensins were adaptively increased and CRAMP was decreased by 24-day
alcohol exposure in WT mice. However, depleting HIF-1α eliminated β-defensin
upregulation and further decreased CRAMP. This, at least partially, explains why
IEhif1α-/- mice developed dysbiosis following alcohol exposure. In contrast,
activation of HIF-1α in epithelial T84 cells inhibited bacterial growth and
increased antimicrobial gene expression. In vivo activation of HIF-1α by DMOG
demonstrated a partial prevention of ALD. However, this observation is not
conclusive because DOMG treatment is not intestine specific. While intestinal
HIF-1α might be beneficial in ALD, hepatic activation of HIF-1α showed
contradictory results [48, 49]. The causative role of gut dysbiosis in IEhif1α-/- mice
in ALD was further demonstrated by sterilization of the gut using non-absorbable
antibiotics. Treatment with ABx reduced ALD regardless the presence or
absence of the HIF-1α gene in mice.
Previous studies in inflammatory bowel disease showed that intestinal HIF1α deficiency causes intestinal leakiness [28, 33]. The current study showed that
IEhif1α-/- mice had an increase in intestinal permeability in ALD [9]. Subsequently,
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bacteria and bacterial products translocated from the intestinal lumen to the
systemic circulation and liver. As shown in our results, IEhif1α-/- mice displayed a
higher LPS level in the serum and an increased E. coli protein in the liver after
alcohol feeding. LPS binds to TLR4 on hepatocytes and Kupffer cells resulting in
hepatic fat accumulation and inflammation in ALD, which is an established and
well-studied mechanism in chronic ALD.
How does HIF-1α impact intestinal barrier function? In addition to the effect
of HIF-1α on antimicrobial peptide regulation, HIF-1α also regulates several
critical factors that are important in intestinal barrier integrity. P-gp functions as a
pump by expelling translocated xenobiotics and bacterial toxins from the
enterocytes into the intestinal lumen. ITF is a mucus modifier that helps to
maintain a dynamic mucus layer. Claudin-1 is a major tight junction protein in the
intestinal epithelial. Previous studies have demonstrated that these proteins are
HIF-1α targets [19, 26, 28]. Reduction in ITF, claudin-1 and P-gp in IEhif1α-/- mice
following alcohol exposure destabilizes gut barrier function resulting in elevated
LPS concentration in serum and E. coli protein in the liver, as seen in our study.
In addition, previous studies also showed that alcohol exposure increased
intestinal Cyp2E1 expression [50], which is responsible for the production of ROS
in the intestine. Furthermore, alcohol feeding significantly increased intestinal
inflammation in IEhif1α-/- mice. Taken together, these multiple mechanisms
contribute to the exacerbated gut barrier dysfunction in IEhif1α-/- mice in ALD.
Our previous studies have shown that long-term (8 weeks) alcohol
exposure decreased HIF-2α protein levels in mouse intestine [37]. However, HIF-
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1α was not evaluated. Given the importance of HIF-1α in the regulation of
intestinal homeostasis, we examined the expression of HIF-1α in this study. To
our surprise, 24-day alcohol exposure increased HIF-1α mRNA expression in WT
mice. However, a decreased HIF-1α expression in the ileum was observed after
48 days alcohol exposure. The HIF-1α target genes, β-defensins, P-gp and ITF
[19, 26, 30] , were also increased in the WT mice by 24 days alcohol exposure.
The increase in HIF-1α signaling resulting from the relatively short alcohol
exposure (24 days) likely represents an adaptive upregulation during the initial
period. However, this adaptive response is decreased with prolonged alcohol
exposure. Depletion of intestinal HIF-1α gene diminished the upregulation of
these antimicrobial peptides and barrier protective genes, suggesting a HIF-1αmediated transcriptional regulation.
Our previous studies demonstrate that the probiotic, LGG, is beneficial in
preventing/treating of ALD in mice. However, the beneficial effects were
diminished when HIF-1α was deleted in the intestine. LGG is able to increase the
luminal concentrations of long-chain fatty acids and short-chain fatty acids in
mice exposed to alcohol. Lactobacilli, in turn, metabolize saturated fatty acids to
keep their growth. On the other hand, supplementation with tributyrin, a prodrug
of butyrate, protects from intestinal tight junction disruption by alcohol [44].
Currently, it is still unclear as to how butyrate protects tight junctions, but other
research showed that butyrate metabolism in in the intestine consumes oxygen
and stabilizes HIF-1α [51], which is protective in the intestinal barrier. Thus, it is
likely that LGG promotes butyrate-producing bacteria growth, and the resulting
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butyrate production increases HIF-1α stabilization and protects the intestinal
barrier. Intestinal HIF-1α depletion abolishes this protective effect of LGG against
alcohol-induced intestinal barrier disruption.
In conclusion, our findings demonstrate that intestinal epithelial HIF-1α is
critically involved in the intestinal pathogenesis of alcohol-induced barrier
disruption and subsequent liver injury. HIF-1α activation regulates gut bacterial
homeostasis though increasing anti-microbial peptides and stabilizes barrier
function via upregulation of P-gp and tight junction proteins. The probiotic, LGG,
exerts its beneficial effects through intestinal HIF-1α-mediated pathways in ALD.
Dietary approaches and pharmacological agents that activate intestinal HIF-1α
could be developed to prevent/treat ALD.
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CHAPTER II
DSS-INDUCED INTESTINAL DAMAGE EXACERBATES LIVER INJURY
BY ACUTE ALCOHOL EXPOSURE IN MICE: ROLE OF INTESTINAL
HYPOXIA-INDUCIBLE FACTOR 1α

INTRODUCTION

An acute form of alcoholic liver disease (ALD), alcoholic hepatitis (AH) is a
specific clinical syndrome characterized by hepatocellular necrosis, jaundice, an
inflammatory reaction with numerous polymorphonuclear leukocytes and fibrosis
in patients with a recent history of heavy alcohol consumption [1–3]. AH has
been linked with excessive alcohol drinking over a prolonged period of time.
However, it is now recognized that many patients diagnosed with AH report
alcohol use over shorter periods of time before diagnosis. Binge drinking is
defined by the National Institute on Alcohol Abuse and Alcoholism as the
consumption of 5 or more drinks by a male or 4 or more drinks by a female in
about 2 hours, resulting in a blood alcohol concentration of 0.08% or greater [4,5].
The importance of the gut-liver axis is increasingly recognized in alcoholic
liver disease and in decompensation in other chronic liver diseases [6–8]. Animal
and human studies have shown that alcohol consumption causes “leaky gut,”
translocation of bacteria and microbial compounds across the intestinal
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basement membrane into the portal and systemic circulation. Emerging evidence
has revealed an acute dose of alcohol increases circulating markers of bacterialproduct translocation across the gut barrier even in healthy individuals[9].
Circulating bacterial products such as lipopolysaccharide (LPS) are one of the
hallmarks of ALD. They can activate Toll-like receptor 4 (TLR-4) signaling
pathways and initiate an innate immune response[10]. However, the mechanisms
for induction of inflammation in ALD have not been clarified completely.
Inflammatory bowel diseases (IBD), chronic intestinal inflammatory
process, are characterized by repeated injury of the intestinal mucosa, loss of the
intestinal epithelial barrier function and microvascular disturbance [11–13].
Exposure to DSS (dextran sulfate sodium) leads to increased intestinal
permeability and mucosal changes in the ileum and colon in experimental
animals [14,15]. This chronic colitis model results in increased portal LPS
concentrations, which may be a clue to the development of ALD in patients with
chronic or binge alcohol consumption. However, the involvement of alcohol
consumption in IBD-associated ALD has not been explored in previous studies.
Observations from both humans and experimental animals suggest that
colonic hypoxia is significantly increased to the gut following both alcohol
exposure and colitis [16,17]. Interestingly, a number of barrier-protective and
anti-microbial peptide genes are critically regulated by hypoxia-inducible factor1a (HIF-1a), including intestinal trefoil factor (ITF), claudin-1, multidrug
resistance gene-1 (MDR1), b-Defensin-1 and CRAMP [18–22]. HIF-1α is
expressed in inflamed mucosa from IBD patients and mouse models of colitis.
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Studies of murine IBD have revealed that loss of epithelial HIF-1α correlates with
more severe clinical symptoms, whereas constitutive activation of HIF-1 is
protective [23]. Our previous studies also determined that intestinal epithelial
specific HIF-1α knockout worsened alcohol-induced liver injury and resulted in a
more severe dysbiosis. Despite this, the role of intestinal HIF-1α in IBD patients
and an animal model of colitis with chronic and binge alcohol consumption has
rarely been examined. According, the aim of this current study was to determine
whether intestinal HIF1α deletion increases intestinal permeability resulting in an
elevation of endotoxemia in a dextran sulfate sodium (DSS)-induced colitis
murine model, and exacerbates acute alcohol-induced intestinal damage and
liver injury.
MATERIALS AND METHODS
Animal Models of Dextran Sulfate Sodium and Alcohol Feeding

C57BL/6J, hif1α-fl/fl, Villin-Cre and CAMP-/- mice were purchased from Jackson
Laboratory (Bar Harbor, ME). IEhif1α-/- mice were generated by crossing hif1α-fl/fl
and Villin-Cre mice as previous described. Colitis was induced by feeding mice 3%
DSS dissolved in drinking water for 7 days, and the mice were killed by
decapitation on the seventh evening. Control mice received water without DSS. A
model of binge alcohol was made by the treatment of mice with EtOH gavage at
a dose of 6 g/kg body weight and the mice were killed 9 h after the administration.
Control mice were gavaged with an iso-caloric amount of dextrose. The DSS plus
alcohol model was produced in mice pre-treated DSS 7 days, then given EtOH
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gavage at a dose of 6 g/kg. The mice were killed 9 h after the ethanol
administration. All animal protocols were approved by the Institutional Animal
Care and Use Committee of the University of Louisville.

Histological analysis
The liver and small intestine tissues were collected in 4% paraformaldehyde
and then imbedded in paraffin. Tissues were cut into 5μm sections and stained
with hematoxylin and eosin (H&E) and analyzed by light microscopy. Apoptotic
cell death in the liver and cell culture was assessed by detection of DNA
fragmentation using an ApopTag peroxidase in situ apoptosis detection kit
(Millipore, Billerica, MA). Goblet cells were stained with Alcian blue (Sigma, St.
Louis, MO) and counterstained with Nuclear Fast Red.

Tissue triglyceride
Liver tissues were homogenized in distilled water and the homogenate was
collected for lipid extraction. Triglyceride content was determined using
commercially available colorimetric kits (Thermo Scientific, Waltham, MA).

Serum ALT and AST assay
Mouse serum was collected by orbital vein bleeding at time of euthanasia. Serum
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were
analyzed by an Infinity kit (Thermo Scientific, Waltham, MA).

57

ELISA assays
IL-6 and TNF-α levels in serum were measured with ELISA assay kits (BD,
Sparks, MD). Serum CRAMP level was measured by ELISA assay kit
(Mybiosource, San Diego, CA).

Endotoxin assay
All material used for harvesting blood and measuring endotoxin was pyrogen free.
An endpoint, chromogenic Limulus amebocyte lysate (LAL) endotoxin kit was
used to determine plasma LPS levels according to the manufacturer’s protocol
(Lonza, Basel, Switzerland).

Immunofluorescent staining of FFPE tissue.
Formalin-fixed paraffin embedded (FFPE) tissue was processed for staining as
described previously with slight modification. Following deparaffinization, antigen
retrieval was performed in unmasking solution (Vector Laboratories, Burlingame,
CA) for 20 min at 125oC in a Decloaking chamber (Biocare Medical, Pacheco,
CA). Unreacted aldehydes were quenched for 10 min with 1% NaBH4. Prior to
blocking, ImageIT enhancer (Invitrogen, Carlsbad, CA) was applied to each
section. Non-specific antibody binding was blocked with either 1% IgG-free BSA
or 5% Normal donkey serum (Jackson Immuno, West Grove, PA) in TBS (Trisbuffered saline), depending on the antibodies used. Primary antibodies were
incubated overnight at 4oC. Sections were washed with TBS and AlexaFluorconjugated secondary antibodies (Invitrogen) were applied for 30 min at room
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temperature. DAPI counterstain (Invitrogen) was used to image nuclei, and slides
were mounted with ProLong gold (Invitrogen). Primary antibodies used were:
TLR-4 (Abcam) and Claudin-1 (Santa Cruz, Dallas, TX).

Western blot analysis
Liver and ileal tissues were lysed on ice for 30 min in IPB (50 mM Tris·HCl, pH
7.4, 150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 1
mM PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 x g for 10
min. The supernatants were collected. An appropriate amount of protein in total
tissue lysates was resolved by SDS-polyacrylamide gel electrophoresis and
transferred onto a polyvinylidene difluoride membrane (Whatman, Sanford, ME).
Membranes were blocked for 1 h in Tris-buffered saline/Tween 20 (10 mM Tris–
HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk
and incubated overnight at 4°C with the different primary antibodies diluted in
blocking buffer. Subsequently, membranes were incubated with peroxidaseconjugated second antibodies. Following treatment with supersignal west HRP
substrate (MilliporeSigma, Billerica, MA), protein bands were detected by a
ChemiDoc Molecular Imager (Bio-Rad, Hercules, CA). Data were normalized to
b-actin.

Quantification of GFP-E.coli translocation toward mesenteric adipose
tissue to liver
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Ampicillin-resistant GFP-E.coli were obtained from R ́emy Burcelin’s lab
(Rangueil Hospital, Department of Therapeutics, Toulouse, France). Five hours
after gavage with 109 GFP-E.coli, mice were sacrificed. Mesenteric adipose
tissue (MAT) and liver were harvested. Tissues were then homogenized in Luria
Broth (LB) (BD, Sparks, MD), plated onto ampicillin-supplemented (100mg/ml)
LB agar, and yellow colonies were enumerated after overnight incubation at 37oC.

Results
Intestinal epithelial Hif1α-deficiency exacerbates DSS-induced colitis
First, the role of intestinal epithelial Hif1α in inflammatory bowel disease
(IBD) was examined in DSS-induced colitis in IEHIF1α-/- mice. IEHIF1α-/- mice
and the control mice were treated with DSS (3%) in drinking water for seven days.
All of mice that received DSS developed typical clinical signs of colitis, including
weight loss, diarrhea and rectal bleeding. As shown in Fig 1A, 7-day DSS
treatment reduced body weight by about 10% in WT mice, but by nearly 30% in
the IEHIF1α-/- mice. IEHIF1α-/- mice had a significant shorter colon compared to
the control mice, which is a symptom of DSS-induced colitis in mice (Fig. 1B).
Overall disease scores were higher in the IEHIF1α-/- mice than in the control mice
(Fig 1C). As expected, DSS treatment significantly increased spleen size,
indicating an increased systemic inflammation. However, there was no difference
in spleen/body weight between control and IEHIF1α-/- mice (Fig. 1D). The
liver/body weight ratio was not changed by DSS treatment in either control mice
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or the IEHIF1α-/- mice (Fig. 1E). H&E staining of liver sections revealed normal
liver histology in both control and the IEHIF1α-/- mice fed DSS (Fig. 1F). The
hepatic triglyceride level and ALT, AST levels confirm the histological observation
(Fig. 1G, H). These results indicate that DSS-induced acute colitis did not affect
liver fat metabolism and liver injury.
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Figure 1. Effect of DSS on clinical symptoms and liver histopathological signs in
a mouse colitis model. (A) Changes in body weights and (B) clinical scores of
IEHIF1α-/- mice and control mice administered 3% DSS; mice were monitored
every day. Body weight values are expressed as a percentage of the starting
body weight. (C) Colons were excised from mice and their lengths were
measured 7 days after initiating DSS administration. Macroscopic features of the
colons. (D, E) Liver/spleen weight to body weight ratio of WT and IEhif1α-/- mice
fed water or DSS. (F) Hematoxylin and eosin staining of the liver sections of
water and DSS WT and IEhif1α-/- mice. Original magnification, ×10. (G) Serum
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities
of water and DSS WT and IEhif1α-/- mice. *P<0.05, ***P<0.001.
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Acute EtOH on DSS increases systemic inflammation
To evaluate the effect of acute alcohol exposure on animals with DSSinduced colitis, we administered EtOH (6 g/kg) by oral gavage 9 hours before
sacrifice on the last day. Acute alcohol did not affect body weight or colon length
(Fig. 2A, B). However, alcohol on DSS treatment significantly increased
spleen/body weight ratio in the IEHIF1α-/- mice compared to the WT mice (Fig.
2C). In addition, alcohol on DSS increased serum TNF- α and IL-6 level in
IEHIF1α-/- mice (Fig. 2D, E), suggesting that intestinal epithelial HIF-1α plays a
critical role in alcohol-induced systemic inflammation.
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Figure 2. Inflammatory responses in binge EtOH on DSS-induced colitis. (A)
Changes in body weights of IEHIF1α-/- mice and control mice administered 3%
DSS plus one binge of 6 g/kg EtOH. (B) Colons were excised from mice and their
lengths were measured 7 days after initiating 3% DSS with EtOH administration.
(C) Spleen weight to body weight ratio of WT and IEhif1α-/- mice fed 3% DSS with
binge EtOH. (D, E) Systemic expression of proinflammatory cytokines TNF-α and
IL-6 in serum. *P<0.05, **P<0.01, ***P<0.001.
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DSS-induced colitis enhances binge alcohol induced hepatic inflammation
Plasma ALT levels were significantly enhanced by acute alcohol
administration in both WT and IEHIF1α-/- mice, while plasma AST showed a
marginal increase (Fig. 3A and 3B). Interestingly, when the mice were pretreated
with DSS, acute EtOH only marginally increased plasma ALT and AST levels in
WT mice, while a significant increase in ALT and AST was observed in the
IEHIF1α-/- mice (Fig. 3A and 3B). However, hepatic TG had only a trend of
increase in both types of mice when the colitis mice were exposed to EtOH (Fig.
3C). H&E staining of the liver sections showed an increase in steatosis in both
types of mice, but the degree of steatosis was higher in the IEHIF1α-/- mice (Fig.
3D).
Next, we measured hepatic apoptosis. TUNEL assay revealed that acute
EtOH administration in DSS-primed mice significantly increased apoptotic cell
death in both types of mice. However, the apoptotic cells were significantly
greater in number in the IEHIF1α-/- mice compared to WT mice (Fig. 3E).
TLR4 mediates the inflammatory effects in the liver in response to
endotoxin (LPS) derived from the gut lumen. Immunofluorescent staining of TLR4
in liver tissues and hepatic TLR4 immunoblotting showed no differences among
groups of WT mice and IEHIF1α-/- mice fed EtOH (Fig. 3F and 3G). However,
alcohol on DSS significantly increased hepatic TLR4 expression in both types of
mice. Comparing the WT mice and IEHIF1α-/- mice, we observed a significant
increase in TLR4 protein level in the livers of IEHIF1α-/- mice (Fig. 3F and 3G).
Taken together, the data presented above demonstrate that DSS pretreatment
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primed mice for acute alcohol-induced liver injury; intestinal epithelial HIF-1α
depletion exacerbated the outcomes.
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Figure 3. IEhif1α-/- mice have exacerbated liver injury by alcohol on DSS
treatment. (A, B) Serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) activities of WT and IEhif1α-/- mice.

Control group

(without DSS; water), binge alcohol group (6 g/kg) and 3% DSS+ 6 g/kg EtOH
administration group. (C) Quantification of hepatic triglyceride content. (D)
Hematoxylin and eosin staining of the liver sections. Original magnification, ×10.
(E) Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)
assay in the liver section, quantitative measurements of TUNEL-positive cells in
liver. Original magnification, ×10. (F) Immunoflorescent staining of Toll-like
receptor 4 (TLR-4) in the liver section. DAPI (blue) was used to counterstain
nuclei.

Original magnification, ×10. (G) TLR-4 protein Western blotting and

quantification of liver tissues normalized by β-actin. *P<0.05, **P<0.01,
***P<0.001.
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IEHIF1α-/- mice exhibit enhanced plasma LPS levels and increased
translocation of bacteria
Translocation of enteric bacteria and bacterial products into the liver plays
an important role in acute alcoholic liver injury [25]. Treatment of EtOH or DSS
alone in either WT mice or IEHIF1α-/- mice caused a marginal increase in plasma
LPS concentration. However, EtOH on DSS treatment significantly increased
plasma LPS levels in IEHIF1α-/- mice, but not in the control mice (Fig. 4A). To
determine the live bacterial translocation, we gavaged mice with ampicillin
resistant- and GFP-labeled E. coli and cultured mesenteric adipose tissue (MAT)
and liver tissues. As shown in Fig 4B, live E. coli cells were identified in the liver
of DSS-primed control mice treated with acute alcohol. Interestingly, the livers of
IEHIF1α-/- mice had significantly increased numbers of E. coli cells, indicating
depletion of intestinal HIF-1α enhanced bacterial translocation to the liver. As
expected, MAT showed a significant numbers of live E. coli upon EtOH treatment
in DSS-primed mice. However, there was no difference between WT mice and
the IEHIF1α-/- mice (Fig 4B, and 4C). Taken together, our data demonstrate that
in the DSS-primed mouse model, acute alcohol enhances the translocation of
bacteria and bacterial products from the intestine lumen to extraenteric tissues
including MAT and liver; intestinal Hif1α deletion exacerbates this translocation.
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Figure 4. Effect of Hif-1α on gut permeability and bacterial translocation. (A)
Serum LPS levels. (B) Macroscopic features of the GFP- E. Coli on the LB agar
by UV light exposure. (C) Numbers of GFP-E. coli CFU/g of MAT and liver in
IEhif1α-/- mice and their corresponding WT controls treated 3% DSS+ 6 g/kg
EtOH, 5 h post-gavage with 109 CFU of GFP-E.coli. *P<0.05, **P<0.01.
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Effect of DSS pretreatment on acute EtOH induced intestinal barrier
dysfunction and CRAMP depletion shows exacerbated liver injury
Goblet cells play a critical role in antimicrobial peptide production and
barrier function. Alcian blue staining of colon tissues showed that EtOH on DSS
treatment significantly decreased goblet cells in WT mice, and this depletion was
more pronounced in IEHIF1α-/- mice (Fig.5A). The histological analysis of the
distal colon revealed marked mucosal damage, characterized by an intense
inflammatory cell infiltrate extending throughout the mucosa and submucosa, and
crypt destruction in IEHIF1α-/- mice (Fig. 5A). To further define the role of Hif1α in
mediating intestinal barrier dysfunction after alcohol administration, we analyzed
expression of claudin-1, one of the tight junction (TJ) proteins in the epithelial
tissues, and the antimicrobial peptide, CRAMP. Immunofluorescence staining of
claudin-1 revealed that IEHIF1α-/- mice showed a lower expression in the ileum
after DSS plus ethanol feeding (Fig. 5B). DSS induced a marked increase in
CRAMP expression in WT mice. However, this elevation was impaired in the
IEHIF1α-/- mice (Fig. 5C). When the DSS-pretreated mice were exposed to EtOH,
CRAMP expression was significantly decreased in WT mice, and the decrease
was more pronounced in the IEHIF1α-/- mice (Fig. 5C). Circulating CRAMP was
increased by DSS pretreatment in WT mice, but not in IEHIF1α-/- mice.
Interestingly, EtOH exposure eliminated the increased CRAMP produced by DSS
in the WT mice (Fig. 5D). Next, we examined the liver injury by EtOH in DSSpretreated CRAMP knockout mice.

Acute EtOH on DSS pretreatment

significantly increased plasma ALT and AST levels in WT mice, and more so in
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the CRAMP knockouts (Fig. 5E).
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Figure 5. Effect of DSS pretreatment on acute EtOH induced intestinal barrier
dysfunction. (A) Alcian blue staining of representative sections from the proximal
colon of WT and IEhif1α-/- mice treated with 3% DSS plus 6 g/kg EtOH.
Quantification of the number of Alcian blue–positive goblet cells per crypt-villus
unit was performed. (B) Immunoflorescent staining of Claudin-1 in the colon
section. DAPI (blue) was used to counterstain nuclei.

(C) CRAMP protein

Western blotting and quantification of colon tissues normalized by β-actin. (D)
Serum level of CRAMP was measured by ELISA kit. (E) Serum alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) activities of WT
and CRAMP-/- mice treated with 3% DSS+ 6 g/kg EtOH. *P<0.05, **P<0.01,
***P<0.001.
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Discussion
The association between colitis and liver disease was first described in the
late 19th century [26,27]. Emerging evidence shows alcohol and high fat diet are
increasingly being recognized as a cause of hepatic steatosis among patients
with IBD[28–31]. Although there are few clinical reports about ALD with IBD
patients, there is no study showing that ulcerative colitis with alcohol exposure
enhances liver injury and liver failure. In this study, we first describe a link
between the colonic inflammatory response and alcohol induced hepatic injury.
In the present study, data obtained showed that in intestinal HIF-1a KO
mice, DSS exposure induced clinical symptoms, systemic inflammatory reaction
and colonic inflammation characterized by increased local pro-inflammatory
mediators and histopathological changes. These observations are similar to
those described in either epithelial HIF-1a−/− mice or HIF-1β−/−mice[32,33].
However, liver injury was not observed in DSS-colitis either WT or KO mice, and
there were no histopathological changes or up regulation of inflammatory
mediators. These results suggest a limited involvement of the liver in the colitis
process, which is in agreement with previous animal and human studies[34–37].
Among these studies, one explained this phenomenon is DSS-induced
experimental colitis leads to endotoxin tolerance for liver, but did not provide
more mechanisms.
The main question in our study was whether colitis can enhance alcohol
induced liver injury. Although liver injury was not observed in DSS-colitis mice,
we considered that the portal endotoxemia (in colitis model) facilitated the liver
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injury induced by other compounds, because small amounts of LPS are known to
enhance susceptibility to various hepatotoxic agents [38]. A recent study showed
that the systemic biologic activity of the increased LPS after alcohol binge
contributed to the increased inflammatory cytokines in liver[9]. In the present
study, contrary to expectation, we observed no change of ALT and AST in the
acute alcohol on DSS-colitis mice compared to ALT and AST in mice exposed
only to an alcohol binge, indicating that exposure of a single alcohol binge
impairs liver to the same extent as does the DSS and alcohol treatment.
However, the most surprising finding is that serum ALT and AST levels
significantly increased in HIF-1a−/− mice after a single binge alcohol on colitis and
this liver injury was confirmed by elevated levels of hepatic pro-inflammatory
mediators and histopathological changes.
Intestinal HIF-1a plays an important role in the colitis model because a
number of barrier-protective genes are critically regulated by HIF-1α, including
intestinal trefoil factor (ITF), CD73, P-glycoprotein (P-gp), cathelicidin (CRAMP),
and claudin-1,muc3 and β-defensin1 (DEFB1) [19–23]. Based on this, we
considered that intestinal HIF-1α deletion might exacerbate gut-permeability and
dampen the intestinal innate immunity response; binge alcohol as the second hit
induced more inflammation and greater gut permeability in colitis mice. Among
these finding, one of the most important results is that the expression of the
antimicrobial peptide, CRAMP, was significantly increased in both colon and
serum, illustrating the attempt to re-establish the disturbed barrier. However, we
did not find the same results in alcohol treatment and in the HIF-1a KO mice.
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According to these results and in light of earlier findings, which demonstrated that
alcohol has the potential to modulate intestinal CRAMP production. Recent
studies have shown that a few antimicrobial peptides (AMPs) also have the
potential to neutralize LPS-induced endotoxic effects. Among these AMPs, the
list included human LL-37 (mouse CRAMP) [39–41]. Although strong binding of
CRAMP to LPS is not sufficient to block LPS biological activity, binding of
CRAMP to LPS aggregates accompanied by aggregate dissociation prevents
LPS from binding to the carrier protein LBP, or alternatively to its receptor, and
hence inhibits cytokine release. Indeed, we showed that CRAMP reduced the
level of mRNA expression of the two cytokines which stimulate by LPS in
RAW264.7 cells. Therefore, we used global CRAMP knockout mice to investigate
our hypothesis. As we expected, binge alcohol on colitis enhanced liver injury in
CRAMP KO mice compared with WT mice. All these results show that the
intestinal HIF-1a - CRAMP pathway plays an important role in intestinal damage
induced by alcohol-induced liver injury.
In summary, we provide new evidence that a concomitant colonic damage
enhances hepatic injury in experimental ALD. Interestingly, the compensatory
upregulation of antimicrobial peptides in mice with colitis was not significantly
expressed in HIF-1a KO mice, and alcohol also further reduced its expression.
This may facilitate gut-driveled LPS, bacteria and cytokine translocation, as
evidenced by increased serum concentration. To our knowledge, this is the first
report which provides conclusive evidence that binge alcohol is a ‘‘second’’ hit,
which is sufficient to induce hepatic inflammation in colitis without intestinal
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CRAMP expression, regulated by HIF-1a gene expression. Our findings may
also provide another mechanism for DSS induced endotoxin tolerance in the liver.
Further studies are necessary to discover the mechanism of decreased intestinal
antimicrobial peptide generation and precisely to determine the CRAMP-bind
LPS in our model.
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LIST OF ABBREVIATIONS

AAH

acute alcoholic hepatitis

ABx

antibiotics

AF

alcohol-fed

ALD

alcoholic liver disease

ALT

alanine aminotransferase

AMPs

antimicrobial peptides

AST

aspartate aminotransferase

CAE

chloracetate esterase

CRAMP

Cathelicidin related antimicrobial peptide

DMOG

dimethyloxalylglycine

DSS

dextran sulfate sodium

E. coli

Escherichia coli

FFPE

formalin-fixed paraffin embedded

GFP

green fluorescent protein

hBD-1, 2

human β-defensin-1, 2

HDL

high-density lipoprotein cholesterol

HIF-1α

hypoxia inducible factor-1α

IBD

inflammatory bowel diseases

ITF

intestinal trefoil factor
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LAL

Limulus amebocyte lysate

LDL

low-density lipoprotein cholesterol

LGG

Lactobacillus rhamnosus GG

LPS

lipopolysaccharide

MAT

mesenteric adipose tissue

MDR1

multidrug resistance protein-1

P-gp

P-glycoprotein

PF

pair-fed

TJ

tight junction

TLR4

Toll-like receptor 4

VLDL

very low-density lipoprotein cholesterol
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